TMO Thermo Fisher Scientific Inc.

$TMO has two green bricks which would make it a buy tomorrow if it doesn't go lower at the open. I posted the daily chart below. I don't like the low volume today: Thermo Fisher Scientific Inc. (NYSE: TMO) has a daily average volume of approximately 2.14 million shares. • Volume Today: 1,099,210 shares traded during the regular session. $XLV Sector and Medical Equipment are both overbought. I'm going to have to pass on TMO.

$TMO , Tuesday 11:18 AM, 27-Oct-2026. A+ Setup / Valid Trigger: All system rules align. Strong weekly trend above a rising 20-EMA, robust sector support in XLV, a controlled 2-red brick pullback to the 195-min 20-EMA with a complete StochRSI reset, and the entry triggered on the 2nd green brick. Position sizing per risk rules (0.75% max capital risk) applied on the next session providing there are still two green bricks on the 195-minute 1% Renko chart.

$TMO is up +47.6% Since this Chart in June 📈 Hope you followed! Turn on Post notifications and follow us on so you don't miss the next one! #PeloCalledit!

$TMO Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $6.68 up 15.37% YoY • Reported revenue of $12.14B up 9.13% YoY

Life sciences and digital marketing aren't the same game, but I enjoy following $TMO alongside $GOAI

$TMO This is a textbook setup, but SPY’s gate is closed, so the verdict is NO NEW LONGS. Setup: The 195-min chart shows a 2-red pullback (691.88, 684.82), a StochRSI reset, and the 2nd green brick printing at 706.00 with SCTR at 93.5. The pullback never lost the 20-EMA. Not confirmed: The 2nd green is live. It only counts if it holds at today’s close, with entry at the next session. If it holds, the stop goes just under 684.82, about 3.0% below the last price. Stale signal: SPY needs a weekly close at 774.48 or higher to print its first green. That can’t happen before Friday. By then TMO’s signal will likely be a 3rd green or later, which is chasing, so wait for a fresh setup.

$TMO Clario closed in March for 9,102 million dollars, and Note 12 in the 10-Q finally shows the allocation. Goodwill was 5,945 million dollars of it, customer relationships another 2,510 million. Same segment took a 244 million dollar held-for-sale loss in Q3 on a pharma services facility it agreed to sell in September.

$TMO Q3 is coming and the AI platform is the wildcard. ISSCA AI just got detailed and if that starts contributing SaaS revenue the margins go even higher. This isnt just a product company anymore

Thermo Fisher $TMO is about to open trading today down by more than 2% following its earnings

$TMO Q3 revenue grew 9% to 12.14 billion dollars. Adjusted EPS was 6.68 dollars, up 15% and ahead of the 6.40 dollar consensus. Segment margins expanded in all four segments. Analytical Instruments margin went from 22.6% to 26.9% on about 6% revenue growth, and Specialty Diagnostics revenue fell about 6% but segment profit still rose about 6%, with margin up to 31.0%. Laboratory Products carried the top line, revenue up 15% to 6.86 billion dollars.

$TMO Reports Wednesday before the open. Zacks consensus is 6.40 dollars of EPS, up 10.5% YoY, on 11.91 billion dollars of revenue, up 7.1%. The segment estimates are pretty uneven though. Life Sciences Solutions is expected up 10.1% and Laboratory Products up 9.8%, while Analytical Instruments is pegged at just plus 2.6% and Specialty Diagnostics is expected down 3%. TMO has beaten the Zacks consensus in each of the last four quarters, average surprise 4.42%.

$TMO cleared 694 on nearly 2x average volume and closed at a record 696.49. Holds above 694 and runs to 755. A close back under 673 and I'm wrong.